The oxidation of heme to biliverdin is facilitated by
a stress-induced enzyme, heme oxygenase-1. This enzyme has antioxidant
properties and plays an important role against inflammation. First case
of heme oxygenase-1 deficiency was reported in 1999 [1]. The key
features of heme oxygenase-1 deficiency, a recently described disorder,
are hemolysis, generalized inflammation, bleeding diathesis, nephropathy
and asplenia [1,2].
An 8-month old child presented with fever for
1-month. He was first of nonconcordant twins, and the sibling was
healthy. On examination, he had dysmorphic facies, frontal bossing,
depressed nasal bridge and large ears. General examination revealed
pallor, and on systemic examination he had hepatomegaly. Investigation
revealed increased inflammatory markers [raised CRP (84 mg/L) and
ferritin (3503 ng/mL)], features of hemolysis [raised LDH (5253 U/L),
SGOT (210 units/L) and SGPT (114 units/L)], anemia and thrombocytopenia.
He was worked up for bicytopenia (EBV, Parvo virus and CMV work up was
negative). Other infections like tuberculosis and HIV were also ruled
out. Bone marrow examination revealed few hemophagocytes. His initial
USG abdomen revealed a normal spleen but on repeat CT abdomen after 6
months, spleen was not seen and only a small focal nodular calcified
area within splenic fossa was seen. In view of the unclear primary
diagnosis, hemophagocytes on marrow, increased liver enzymes and
bicytopenia, he was started on oral steroids, pending further
investigations. He improved, fever disappeared and liver enzymes
returned to normal, but he needed transfusion once in 2-3 months.
However, on tapering steroids, fever reappeared and he became pale
again. He was readmitted for investigations. USG showed absent spleen.
Hemoglobin electrophoresis showed sickle cell trait.
In view of features suggestive of autoinflammatory
disorder, transfusion dependent anemia, and auto-splenectomy, clinical
exome sequencing was done, which revealed homozygous nonsense variation
in exon 3 of HMOX1 gene (OMIM*141250) which causes human heme
hemoxygenase-1 deficiency, confirmed by Sanger sequencing. Both parents
were asymptomatic heterozygous carriers of the pathogenic variation
detected in our patient.
When comparing our case with previous cases published
in literature, we found our child had delayed development, growth
retardation and dysmorphic features as reported earlier. He presented
with fever but did not have lymphadenopathy or rash as seen in earlier
cases. Also, he did not have asplenia from the beginning but had
autosplenectomy during the course of treatment. Laboratory features
similar in our case to the previous cases were, features of hemolysis
(raised LDH and SGOT), raised inflammatory markers (raised CRP, ferritin).
Our case is different from previously reported cases as he did not have
coagulation abnormalities, features of nephritis or abnormal lipid
profile [1-3]. Subsequently our patient developed acute arterial stroke
confirmed on MRI and later was transfusion dependent. He succumbed to
his illness at the age of 3½ years at a peripheral hospital.
Human heme oxygenase-1 deficiency is a disease which
is known to be associated with impaired stress hematopoiesis. This
results in marked red blood cell fragmentation, intravascular hemolysis,
coagulation abnormalities and endothelial damage. This leads to deposits
in the kidney and liver. Clinical features include persistent hemolytic
anemia, asplenia, nephritis, generalized erythematous rash, growth
retardation and hepatomegaly. There is one case report of successful HLA
matched stem cell transplantation in the literature.
Though a rare disorder, if a patient presents with
features of hemolysis, generalized inflammation, bleeding diathesis,
nephro-pathy and asplenia, diagnosis of human heme oxygenase-1
deficiency should be considered. All the features may not be present as
our patient did not have coagulation abnormalities, features of
nephritis or abnormal lipid profile. From our case, it is evident that
the child had autosplenectomy, whereas literature suggests congenital
asplenia.
1. Kawashima A, Oda Y, Yachie A, et al. Heme
oxygenase-1 deficiency: The first autopsy case. Hum Pathol. 2002;33:
125-30.
2. Radhakrishnan N, Yadav SP, Sachdeva A, et al.
Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis,
and asplenia. J Pediatr Hematol Oncol. 2011; 33:74-8.
3. Jarmi T, Agarwal A. Heme oxygenase and renal
disease. Curr Hyperten Rep. 2009;11:56-62.
4. Yadav SP, Thakkar D, Kohli S, Nivargi S, Rastogi
N. Human heme-oxygenase-1 deficiency treated successfully by matched
sibling donor allogeneic stem cell transplant. Biol Blood Marrow
Transplant. 2018;24:S443.